Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628507 · ClinicalTrials.gov registry record
Cell Free Preimplantation Genetic Testing
A clinical trial, sponsored by Genomic Prediction.
- Not yet
- Registry status
- 200
- Enrollment target
NCT04628507: Clinical Trial study, sponsored by Genomic Prediction.
NCT04628507 is a clinical trial that has not yet begun recruiting, run by Genomic Prediction. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04628507 has not yet begun recruiting, sponsored by Genomic Prediction.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study aims to develop preimplantation genetic testing methods from embryo culture media (cell free). Genetic testing of culture media will be compared to conventional methods based on embryo biopsies.
Primary Outcome
Concordance rates with PGT diagnosis from trophectoderm biopsies
Interventions
- OTHER Spent media collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-06-11 |
| Est. Completion | 2027-12-11 |
What is known before NCT04628507 opens enrollment
NCT04628507 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Spent media collection is the first listed.
NCT04628507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04628507 about?
NCT04628507 is a clinical study titled "Cell Free Preimplantation Genetic Testing". This study aims to develop preimplantation genetic testing methods from embryo culture media (cell free). Genetic testing of culture media will be compared to conventional methods based on embryo biopsies.
What is the current status of trial NCT04628507?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2026-06-11. Estimated completion is 2027-12-11.
What interventions are being tested in trial NCT04628507?
The interventions under investigation include: Spent media collection (OTHER).
Who is sponsoring clinical trial NCT04628507?
This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI